Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F1V31
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,277
Award facts
- Contract value 100% obligated
- $19,277.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,277.49 delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml format, with a completion date of January 16, 2026. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract is a child order issued under a significantly larger Indefinite Delivery Contract (IDC) vehicle, the DLA Troop Support Medical SPE2DX prime vendor contract valued at $999,999,999.00 and extending through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major vendor in the DLA's pharmaceutical supply chain, the company routinely fulfills delivery orders for brand-name and generic medications across multiple therapeutic domains, including specialty drugs, vaccines, and medical devices. This contract for Cosentyx, a immunosuppressive medication used in treating autoimmune conditions, exemplifies the company's role in supplying specialized pharmaceutical products to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1V31?
SPE2DR26F1V31 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F1V31 worth?
The government has obligated $19,277 on SPE2DR26F1V31.
Is contract SPE2DR26F1V31 an order under another contract?
Yes. SPE2DR26F1V31 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1V31 competed?
The extent of competition for SPE2DR26F1V31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award